NCT00000194
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 3
ConditionsOpioid-Related Disorders
DrugsCycloserine
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Opioid-Related Disorders
- Sponsor
- Yale University
- Locations
- 1
- Primary Endpoint
- Phsyiological, neuroendocrine measures of naloxone
- Status
- Withdrawn
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to study the effects of cycloserine on naloxone-precipitated opiate withdrawal.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Phsyiological, neuroendocrine measures of naloxone
Behavioral, subjective, measures of naloxone-preci
Study Sites (1)
Loading locations...
Similar Trials
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 1 - 1Opioid-Related DisordersNCT00000192Yale University
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 4 - 4Opioid-Related DisordersNCT00000195Yale University
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 5 - 5Opioid-Related DisordersNCT00000196Yale University
Withdrawn
Phase 2
Neurobiology of Opioid Dependence: 2 - 2Opioid-Related DisordersNCT00000193Yale University
Completed
Phase 4
The Impact of the Opiate Antagonist Naltrexone on the Emotional Valence of DreamsNeuroscience of Dreaming, HealthyNCT02792140University of Bern32